WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Proctor, W. R.
Right arrow Articles by Dunwiddie, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Proctor, W. R.
Right arrow Articles by Dunwiddie, T. V.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 6, 3161-3168, Copyright © 1986 by Society for Neuroscience


ARTICLE

Facilitatory action of etomidate and pentobarbital on recurrent inhibition in rat hippocampal pyramidal neurons

WR Proctor, M Mynlieff and TV Dunwiddie

Biochemical studies have shown that the non-barbiturate anesthetic etomidate can interact in a stereoselective, barbiturate-like fashion with the GABA/benzodiazepine receptor complex, enhancing both benzodiazepine and GABA binding, but its electrophysiological effects upon the mammalian CNS are largely unknown. The present investigations were designed to characterize the electrophysiological effects of etomidate on the recurrent GABAergic inhibitory pathway in the CA1 region of the rat in vitro hippocampal slice and to compare the actions of etomidate to those of pentobarbital. Electrical stimulation of the alveus elicited a biphasic hyperpolarizing response, consisting of an initial bicuculline-sensitive GABAergic IPSP. This was followed by a second component, termed the late hyperpolarizing potential (LHP), which is thought to reflect an increase in potassium conductance. Both pentobarbital (100 microM) and (+)-etomidate (10 microM) markedly increased the duration of the initial GABA-mediated IPSP, and frequently increased its amplitude as well. However, no significant effects of either of these drugs were observed on the LHP. Together with previous biochemical findings, our data suggest that the depressant effects of etomidate and barbiturates on the nervous system may reflect a common action upon a stereoselective receptor site intimately associated with bicuculline-sensitive GABA receptors and the chloride ion channel.


This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
J. Engelmann, J. Bacelo, E. van den Burg, and K. Grant
Sensory and Motor Effects of Etomidate Anesthesia
J Neurophysiol, February 1, 2006; 95(2): 1231 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Z Xie, K. P. M Currie, and A. P Fox
Etomidate elevates intracellular calcium levels and promotes catecholamine secretion in bovine chromaffin cells
J. Physiol., November 1, 2004; 560(3): 677 - 690.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Sanna, A. Murgia, A. Casula, and G. Biggio
Differential Subunit Dependence of the Actions of the General Anesthetics Alphaxalone and Etomidate at gamma -Aminobutyric Acid Type A Receptors Expressed in Xenopus laevis Oocytes
Mol. Pharmacol., March 1, 1997; 51(3): 484 - 490.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-